Literature DB >> 17266645

Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding.

Abolfazl Barzegar1, Ali A Moosavi-Movahedi, Naghmeh Sattarahmady, Mohammad A Hosseinpour-Faizi, Mohammad Aminbakhsh, Faizan Ahmad, Ali A Saboury, Mohammad R Ganjali, Parviz Norouzi.   

Abstract

Modification of proteins by nonenzymatic glycation is one of the underlying factors that contribute to the development of the complications of diabetes. Human serum albumin (HSA) is one of the major targets of interaction with glucose through the Maillard reaction. The effects of 1 and 5 mg/ml glucose concentrations, which are consistent with blood glucose levels found in diabetic patients, on human serum albumin were studied by circular dichroism and fluorescence spectroscopy in sodium phosphate buffer, pH 7.4. Partial denaturation and changes in the structural integrity of HSA are caused by glycation at lower (1 mg/ml) and higher (5 mg/ml) concentrations of glucose. To study the relationship between structure and function, we investigated the interaction of L-tryptophan (L-Trp) with glycated and non-glycated HSA. The results showed that L-Trp, as the only free amino acid that substantially binds to HSA, has a lower affinity for the glycated form (especially at low concentrations of glucose) than for non-glycated HSA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17266645     DOI: 10.2174/092986607779117191

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  15 in total

1.  The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.

Authors:  K S Joseph; David S Hage
Journal:  J Pharm Biomed Anal       Date:  2010-05-06       Impact factor: 3.935

2.  Comparison of modification sites formed on human serum albumin at various stages of glycation.

Authors:  Omar S Barnaby; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-10-27       Impact factor: 3.786

3.  Existence of different structural intermediates and aggregates on the folding pathway of ovalbumin.

Authors:  Afshin Iram; Aabgeena Naeem
Journal:  J Fluoresc       Date:  2011-08-12       Impact factor: 2.217

Review 4.  Glycated albumin: from biochemistry and laboratory medicine to clinical practice.

Authors:  Elena Dozio; Nicola Di Gaetano; Peter Findeisen; Massimiliano Marco Corsi Romanelli
Journal:  Endocrine       Date:  2016-09-13       Impact factor: 3.633

Review 5.  An overview of in vitro and in vivo glycation of albumin: a potential disease marker in diabetes mellitus.

Authors:  Km Neelofar; Jamal Ahmad
Journal:  Glycoconj J       Date:  2017-08-15       Impact factor: 2.916

6.  Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.

Authors:  Omar S Barnaby; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2011-05-13       Impact factor: 3.786

7.  Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin.

Authors:  Jeanethe Anguizola; K S Joseph; Omar S Barnaby; Ryan Matsuda; Guadalupe Alvarado; William Clarke; Ronald L Cerny; David S Hage
Journal:  Anal Chem       Date:  2013-04-17       Impact factor: 6.986

8.  Emerging trends in optical sensing of glycemic markers for diabetes monitoring.

Authors:  Rishikesh Pandey; Narahara Chari Dingari; Nicolas Spegazzini; Ramachandra R Dasari; Gary L Horowitz; Ishan Barman
Journal:  Trends Analyt Chem       Date:  2015-01-01       Impact factor: 12.296

Review 9.  Review: Glycation of human serum albumin.

Authors:  Jeanethe Anguizola; Ryan Matsuda; Omar S Barnaby; K S Hoy; Chunling Wa; Erin DeBolt; Michelle Koke; David S Hage
Journal:  Clin Chim Acta       Date:  2013-07-24       Impact factor: 3.786

10.  Effects of Fatty Acids and Glycation on Drug Interactions with Human Serum Albumin.

Authors:  Jeanethe A Anguizola; Sara B G Basiaga; David S Hage
Journal:  Curr Metabolomics       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.